DK0512071T3 - Fremgangsmåde og sammensætninger til inhibering af angiogenese - Google Patents

Fremgangsmåde og sammensætninger til inhibering af angiogenese

Info

Publication number
DK0512071T3
DK0512071T3 DK91904851.2T DK91904851T DK0512071T3 DK 0512071 T3 DK0512071 T3 DK 0512071T3 DK 91904851 T DK91904851 T DK 91904851T DK 0512071 T3 DK0512071 T3 DK 0512071T3
Authority
DK
Denmark
Prior art keywords
collagenase
inhibitor
compositions
specific
methods
Prior art date
Application number
DK91904851.2T
Other languages
Danish (da)
English (en)
Inventor
Marsha A Moses
Judith Sudhalter
Original Assignee
Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital filed Critical Childrens Hospital
Application granted granted Critical
Publication of DK0512071T3 publication Critical patent/DK0512071T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK91904851.2T 1990-01-25 1991-01-25 Fremgangsmåde og sammensætninger til inhibering af angiogenese DK0512071T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47006790A 1990-01-25 1990-01-25
US59155990A 1990-10-02 1990-10-02

Publications (1)

Publication Number Publication Date
DK0512071T3 true DK0512071T3 (da) 1996-11-25

Family

ID=27042958

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91904851.2T DK0512071T3 (da) 1990-01-25 1991-01-25 Fremgangsmåde og sammensætninger til inhibering af angiogenese

Country Status (10)

Country Link
EP (1) EP0512071B1 (de)
JP (1) JPH06509791A (de)
AT (1) ATE144710T1 (de)
AU (1) AU652744B2 (de)
CA (1) CA2074725A1 (de)
DE (1) DE69122956T2 (de)
DK (1) DK0512071T3 (de)
ES (1) ES2093699T3 (de)
GR (1) GR3021925T3 (de)
WO (1) WO1991011193A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
DE4106570A1 (de) * 1991-03-01 1992-09-03 Max Planck Gesellschaft Neue inhibitoren der endothelzell-proliferation
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
DE69435342D1 (de) * 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-Angiogene Mittel und Verfahren zu deren Verwendung
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
AU728873B2 (en) * 1993-07-19 2001-01-18 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
AU771815B2 (en) * 1993-07-19 2004-04-01 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
US5837680A (en) * 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
ATE467403T1 (de) 2000-10-16 2010-05-15 Conor Medsystems Inc Expandierbare medizinische vorrichtung zur freisetzung eines heilmittels
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
AU2003252039A1 (en) * 2002-07-23 2004-02-09 Vegenics Limited Methods and compositions for activating or inhibiting vegf-d and vegf-c
WO2004087214A1 (en) 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
WO2014038866A1 (ko) * 2012-09-05 2014-03-13 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재
KR101539700B1 (ko) * 2012-09-05 2015-07-28 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
US5260059A (en) * 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor

Also Published As

Publication number Publication date
CA2074725A1 (en) 1991-07-26
JPH06509791A (ja) 1994-11-02
AU7335191A (en) 1991-08-21
WO1991011193A1 (en) 1991-08-08
DE69122956T2 (de) 1997-05-22
ATE144710T1 (de) 1996-11-15
DE69122956D1 (de) 1996-12-05
ES2093699T3 (es) 1997-01-01
GR3021925T3 (en) 1997-03-31
EP0512071A4 (en) 1993-05-05
EP0512071A1 (de) 1992-11-11
AU652744B2 (en) 1994-09-08
EP0512071B1 (de) 1996-10-30

Similar Documents

Publication Publication Date Title
DK0512071T3 (da) Fremgangsmåde og sammensætninger til inhibering af angiogenese
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
ATE278397T1 (de) Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
ID28658A (id) Senyawa yang menghambat pengikatan integrin pada reseptornya
UA40578C2 (uk) Сульфоніламінопіримідини і фармацевтичний препарат на їх основі
NO991100L (no) Assosiasjon av NO-syntaseinhibitorer med feller for reaktive oksygenformer
DK1203766T3 (da) Carboxylisyrederivater, der hæmmer bindingen af integriner til deres receptorer
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
BR9811099A (pt) Inibidores de urocinase
ATE360419T1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
DK0817646T3 (da) Fremgangsmåder til behandling af inflammation og præparater derfor
ATE240100T1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
DK0644768T3 (da) Fremgangsmåder og præparater til inhibering af endotelcelle- og fibrinogenfremkaldt inflammation
ID19401A (id) N-sianoimina trisiklik baru yang berguna sebagai inhibitor farnesil-protein transferase